Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat

Molecular Nutrition and Food Research

Volumn 54, Issue 10, 2010, Pages 1436-1444

  Lymbury, Robyn S ^a   Marino, Matthew J ^a   Perkins, Anthony V ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Glutathione peroxidase; Heart failure; Hypertension; Selenium; Thioredoxin reductase

Indexed keywords

GLUTATHIONE PEROXIDASE; SELENIUM; THIOREDOXIN REDUCTASE;

AGING; ANIMAL; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; DIET; DIET THERAPY; DISEASE COURSE; ECHOGRAPHY; ENZYMOLOGY; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE; HYPERTENSION; MALE; METABOLISM; MORTALITY; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN CARBONYLATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SURVIVAL; WISTAR KYOTO RAT;

AGING; ANIMALS; BLOOD PRESSURE; DEFICIENCY DISEASES; DIET; DISEASE PROGRESSION; GLUTATHIONE PEROXIDASE; HEART FAILURE; HEART VENTRICLES; HYPERTENSION; MALE; MYOCARDIUM; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SELENIUM; SURVIVAL ANALYSIS; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 78751532594     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000012     Document Type: Article

References (46)

1. Touyz, R. M., Schiffrin, E. L., Reactive oxygen species in vascular biology: implications in hypertension. Histochem. Cell Biol. 2004, 122, 339–352.
2. Rodriguez_Iturbe, B., Zhan, C. D., Quiroz, Y., Sindhu, R. K., Vaziri, N. D., Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension (Online) 2003, 41, 341–346.
3. Witte, K. K., Clark, A. L., Cleland, J. G., Chronic heart failure and micronutrients. J. Am. Coll. Cardiol. 2001, 37, 1765–1774.
4. de Lorgeril, M., Salen, P., Accominotti, M., Cadau, M. et al., Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Euro. J. Heart Failure 2001, 3, 661–669.
5. Byrne, J. A., Grieve, D. J., Cave, A. C., Shah, A. M., Oxidative stress and heart failure. Archives Des Maladies Du Coeur Et Des Vaisseaux 2003, 96, 214–221.
6. Grieve, D. J., Shah, A. M., Oxidative stress in heart failure. More than just damage. Eur. Heart J. 2003, 24, 2161–2163.
7. Poltronieri, R., Cevese, A., Sbarbati, A., Protective effect of selenium in cardiac ischemia and reperfusion. Cardio-science 1992, 3, 155–160.
8. Venardos, K., Harrison, G., Headrick, J., Perkins, A., Selenium supplementation and ischemia-reperfusion injury in rats. Redox. Rep. 2004, 9, 317–320.
9. Venardos, K., Harrison, G., Headrick, J., Perkins, A., Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J. Trace Elem. Med. Biol. 2004, 18, 81–88.
10. Tanguy, S., Boucher, F., Besse, S., Ducros, V. et al., Trace elements and cardioprotection: increasing endogenous glutathione peroxidase activity by oral selenium supplementation in rats limits reperfusion-induced arrhythmias. J. Trace Elem. Med. Biol. 1998, 12, 28–38.
11. Toufektsian, M. C., Boucher, F., Pucheu, S., Tanguy, S. et al., Effects of selenium deficiency on the response of cardiac tissue to ischemia and reperfusion. Toxicology 2000, 148, 125–132.
12. Brown, K. M., Pickard, K., Nicol, F., Beckett, G. J. et al., Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphoctyes, granulo-cytes, platelets and erythrocytes. Clin. Sci. 2000, 98, 593–599.
13. Tanguy, S., Toufektsian, M. C., Besse, S., Ducros, V. et al., Dietary selenium intake affects cardiac susceptibility to ischaemia/reperfusion in male senescent rats. Age Ageing 2003, 32, 273–278.
14. Allan, C. B., Lacourciere, G. M., Stadtman, T. C., Responsiveness of selenoproteins to dietary selenium. Ann. Rev. Nutr. 1999, 19, 1–16.
15. Doggrell, S. A., Brown, L., Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc. Res. 1998, 39, 89–105.
16. Brown, L., Fenning, A., Chan, V., Loch, D. et al., Echo-cardiographic assessment of cardiac structure and function in rats. Heart Lung Circ. 2002, 11, 167–173.
17. Kogler, H., Fraser, H., McCune, S., Altschuld, R., Marban, E., Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium. Cardiovasc. Res. 2003, 59, 582–592.
18. Dumitrescu, C., Narayan, P., Efimov, I. R., Cheng, Y. et al., Mechanical alternans and restitution in failing SHHF rat left ventricles. Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H1320–H1326.
19. Ferrara, C. M., Sherman, W. M., Leenders, N., McCune, S. A., Roehrig, K., Exercise training and the glucose transport system in obese SHHF/Mcc-fa(cp) rats. J. Appl. Physiol. 1996, 81, 1670–1676.
20. Flohe, L., Gunzler, W. A., Assays of glutathione peroxidase. Methods Enzymol. 1984, 105, 114–121.
21. Smith, A. D., Levander, O. A., High-throughput 96-well microplate assays for determining specific activities of glutathione peroxidase and thioredoxin reductase. Methods Enzymol. 2002, 347, 113–121.
22. Arner, E. S., Zhong, L., Holmgren, A., Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 1999, 300, 226–239.
23. Buss, I. H., Winterbourn, C. C., Protein carbonyl measurement by ELISA. Methods Mol. Biol. 2002, 186, 123–128.
24. Alamdari, D. H., Kostidou, E., Paletas, K., Sarigianni, M. et al., High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein. Free Radic. Biol. Med. 2005, 39, 1362–1367.
25. Winterbourn, C. C., Buss, I. H., Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol. 1999, 300, 106–111.
26. Pepe, S., Leong, J. Y., Van der Merwe, J., Marasco, S. F. et al., Targeting oxidative stress in surgery: effects of ageing and therapy. Exp. Gerontol. 2008, 43, 653–657.
27. Bussemaker, E., Popp, R., Fisslthaler, B., Larson, C. M. et al., Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery. Hypertension 2003, 42, 562–568.
28. Cooke, C.-L. M., Davidge, S. T., Peroxynitrite increases iNOS through NF-kappa B and decreases prostacyclin synthase in endothelial cells. Am. J. Physiol. Cell Physiol. 2002, 282, C395–C402.
29. Wilcox, C. S., Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R913–R935.
30. Forgione, M. A., Weiss, N., Heydrick, S., Cap, A. et al., Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H1255–H1261.
31. Mallat, Z., Philip, I., Lebret, M., Chatel, D. et al., Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998, 97, 1536–1539.
32. Cracowski, J. L., Isoprostanes: an emerging role in vascular physiology and disease? Chem. Phys. Lipids 2004, 128, 75–83.
33. Bergman, M. R., Kao, R. H., McCune, S. A., Holycross, B. J., Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats. Am. J. Physiol. 1999, 277, H543–H550.
34. Zhan, C. D., Sindhu, R. K., Vaziri, N. D., Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int. 2004, 65, 219–227.
35. Manning, R. D., Jr., Tian, N., Meng, S., Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am. J. Nephrol. 2005, 25, 311–317.
36. Touyz, R. M., Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004, 44, 248–252.
37. Wilcox, C. S., Welch, W. J., Oxidative stress: cause or consequence of hypertension. Exp. Biol. Med. (Maywood) 2001, 226, 619–620.
38. Cai, H., Harrison, D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 2000, 87, 840–844.
39. Tsutsui, H., Ide, T., Kinugawa, S., Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid. Redox Signal. 2006, 8, 1737–1744.
40. Dhalla, A. K., Hill, M. F., Singal, P. K., Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 1996, 28, 506–514.
41. Toussaint, O., Houbion, A., Remacle, J., Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity. Toxicology 1993, 81, 89–101.
42. Blankenberg, S., Rupprecht, H. J., Bickel, C., Torzewski, M. et al., Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N. Engl. J. Med. 2003, 349, 1605–1613.
43. Dhalla, A. K., Singal, P. K., Antioxidant changes in hyper-trophied and failing guinea pig hearts. Am. J. Physiol. 1994, 266, H1280–H1285.
44. Shiomi, T., Tsutsui, H., Matsusaka, H., Murakami, K. et al., Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004, 109, 544–549.
45. Tinggi, U., Essentiality and toxicity of selenium and its status in Australia: a review. Toxicology Lett. 2003, 137, 103–110.
46. Shrimali, R. K., Weaver, J. A., Miller, G. F., Starost, M. F. et al., Selenoprotein expression is essential in endothelial cell development and cardiac muscle function. Neuro-muscul. Disord. 2007, 17, 135–142.